GILLES BARONE-ROCHETTE | Medicine and Dentistry | Excellence in Research

Published on by Global Academic Awards

Prof. Dr. GILLES BARONE-ROCHETTE | Medicine and Dentistry | Excellence in Research

Cardiology, Grenoble Alpes University Hospital, France.

Gilles Barone-Rochette is a distinguished French cardiologist, currently a Professor of Cardiology at Grenoble Alpes University Hospital. With an extensive academic background, including an MD and PhD, he has significantly contributed to cardiovascular research and education. As the leader of multiple research units and the Competence Centre for Cardiomyopathies, his work focuses on innovative cardiovascular imaging and interventional cardiology. Additionally, Barone-Rochette has dedicated over two decades to teaching medical students and residents, shaping future cardiologists. His active involvement in prestigious medical societies and leadership roles further underscores his exceptional qualifications for the Research for Excellence in Research award.

Publication Profile :

Scopus

Academic Qualifications :

Barone-Rochette’s extensive education, from his medical studies at the University of Montpellier to multiple specialized diplomas and certifications, highlights his commitment to excellence in cardiology. His research-focused scholarship on arterial properties post-coronary syndrome underscores his dedication to innovative studies in cardiovascular health, establishing him as a well-rounded expert in the field.

Professional Experience :

Gilles Barone-Rochette has extensive professional experience in cardiology, currently serving as a Professor of Cardiology and a leading researcher at Grenoble Alpes University Hospital. Since September 2015, he has been instrumental in advancing cardiovascular care, overseeing the Cardiac Diagnostic and Interventional Unit and leading the Cardiology Research Unit. His previous role as Assistant Professor in the intensive care unit at the same hospital laid a strong foundation for his clinical expertise. With a commitment to teaching, Barone-Rochette has educated medical students and residents in cardiovascular disease and imaging, fostering the next generation of healthcare professionals.

Research Contributions :

As the leader of various research units, including the Cardiology Research Unit and the Competence Centre for Cardiomyopathies, Barone-Rochette has significantly contributed to cardiology research. His involvement in projects focused on cardiovascular imaging and interventional cardiology showcases his innovative approach and capacity for collaborative research efforts, further solidifying his status as an influential researcher.

Award And Recognition :

Gilles Barone-Rochette has been recognized for his outstanding contributions to cardiology and medical education. As a professor at Grenoble Alpes University Hospital, he has led numerous groundbreaking research initiatives in cardiovascular imaging and cardiomyopathies, earning him accolades from both national and international medical societies. His commitment to training future cardiologists has been acknowledged through multiple teaching awards, reflecting his impact on medical education. Barone-Rochette’s active involvement in prestigious organizations, including the French Society of Cardiology and the European Society of Cardiology, further highlights his dedication to advancing cardiovascular research and improving patient care in the field.

Conclusion :

Given Gilles Barone-Rochette’s exemplary qualifications, impactful research, and unwavering commitment to education, he stands out as an exceptional candidate for the Research for Excellence in Research award. His contributions to cardiology research and his leadership in training future healthcare professionals position him as a valuable asset to the medical community and a worthy recipient of this recognition.

Publication Top Notes :

  • Coronary microvascular dysfunction and atrial reservoir function 🌟 – Citations: 0 – Year: 2024
  • Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial 📊 – Citations: 4 – Year: 2024
  • Is coronary artery disease screening by imaging in patients with chronic kidney disease necessary? ❓ – Citations: 0 – Year: 2024
  • Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial 📈 – Citations: 0 – Year: 2024
  • New Method CMR-Guided Endomyocardial Biopsy in Suspicion Context of Isolated Cardiac Sarcoidosis 🧬 – Citations: 0 – Year: 2024
  • Coronary disorder is not necessarily caused exclusively by coronary microvascular dysfunction in hypertrophic cardiomyopathy 🔍 – Citations: 0 – Year: 2024
  • Myocardial Infarction with no obstructive coronary arteries: Imaging plays a central role ❤️ – Citations: 0 – Year: 2024
  • Coronary microvascular dysfunction as assessed by multimodal diagnostic imaging in patients with hypertrophic cardiomyopathy is related to the severity of cardiac dysfunction 📉 – Citations: 0 – Year: 2024
  • Segmentation of cardiac infarction in delayed-enhancement MRI using probability map and transformers-based neural networks 🖥️ – Citations: 1 – Year: 2023
  • Assessment of the Objective Effect of Virtual Reality for Preoperative Anxiety in Interventional Cardiology 🎮 – Citations: 0 – Year: 2023

Miguel Virseda-Chamorro | Medicine and Dentistry | Best Researcher Award

Published on by Global Academic Awards

Dr. Miguel Virseda-Chamorro | Medicine and Dentistry | Best Researcher Award

Dr. Miguel Virseda-Chamorro, Hospital Nacional de parapléjicos, Spain

Dr. Miguel Virseda-Chamorro is a distinguished urologist with extensive expertise in urodynamics and pelvic floor disorders. He earned his MD from the University of Valencia in 1981 and specialized in Urology at Gómez Ulla Hospital in 1990. He holds a PhD, awarded cum laude in 1992, and completed further education in Health Sciences Statistics. Dr. Virseda is a Fellow of the European Board of Urology and has contributed to major scientific journals. Recognized with several prestigious awards, his research has impacted functional urology and neurogenic bladder treatment. He is fluent in multiple languages and an active member of several urological societies. 🏥🧬📊

Publication Profile

Scopus

Orcid

Academic Formation and Specializations

Dr. Virseda-Chamorro has an impressive academic trajectory, beginning with a Licenciatura in Medicine and Surgery from the University of Valencia (1981) and multiple specialized courses in Urology and Medical Aeronautics. He has also pursued advanced degrees, including a Master in Health Sciences Design and Statistics (2001), which supports his clinical research. His PhD in Urology, awarded with distinction, further underscores his expertise in the field.

Awards and Distinctions

His outstanding contributions have been recognized through several prestigious awards, such as the Best Doctoral Thesis Awards (1992, 1995), and multiple honors from the Spanish Urology Association for his groundbreaking research. These recognitions validate his impact on the field of urology, particularly in areas like urodynamic models and pelvic prolapse treatment.

Teaching and Clinical Trials

Dr. Virseda-Chamorro has also made significant contributions to medical education, leading various courses on pelvic floor treatment and urodynamic pediatric pathologies. His participation in numerous clinical trials, such as evaluating the efficacy of beta-3 agonists for overactive bladder, shows his ongoing commitment to advancing medical knowledge and patient care.

Conclusion

Dr. Miguel Virseda-Chamorro’s rich academic background, clinical expertise, significant research contributions, and numerous honors make him an ideal candidate for the Best Researcher Award. His dedication to both clinical practice and advancing scientific understanding in urology highlights his qualification for this prestigious recognition.

 

Publication Top Notes

  • Can We Differentiate Between Organic and Functional Bladder Outlet Obstruction in Males With Parkinson’s Disease? (2024)  🧠📅
  • Factors Influencing Postoperative Overactive Bladder after Adjustable Trans-Obturator Male System Implantation for Male Stress Incontinence following Prostatectomy (2023) – 1 citation 💉📅
  • Update on Adjustable Trans-Obturator Male System (ATOMS) for Male Incontinence after Prostate Cancer Surgery (2023) – 4 citations 🦠📅
  • ATOMS in Patients with Post-Prostatectomy Incontinence and Previously Treated Urethral Stricture or Bladder Neck Contracture (2022) – 6 citations 🚻📅
  • Functional Changes during the Voiding Phase in Men with Non-Neurogenic Detrusor Underactivity Undergoing Bladder Catheterization (2022)  🧬📅
  • Compression or Obstruction: Analysis of the Function of ATOMS Based on Pre- and Postoperative Urodynamic Data (2022) – 4 citations 🛠️📅
  • Urodynamics of Urinary Retention in Guillain-Barré Syndrome Post-Infection by SARS-CoV-2 (2022) – 1 citation 🌐📅
  • Influence of ATOMS Implant on the Voiding Phase of Patients with Post-Prostatectomy Urinary Incontinence (2022) – 3 citations 🚽📅
  • Prevalence and Risk Factors for Lower Urinary Tract Symptoms after Robotic Sacrocolpopexy (2021) – 🤖📅
  • Long-term Outcome of ATOMS for Stress Urinary Incontinence in the Iberian Multicentre Study (2020) – 17 citations 📊📅

 

 

 

 

Mehmet Nur Kaya | Medicine and Dentistry | Young Scientist Award

Published on by Global Academic Awards

Dr. Mehmet Nur Kaya | Medicine and Dentistry | Young Scientist Award

researcher, Gülhane Training and Research Hospital,  Rheumatology Department , Turkey

The study titled “Impact of Central Sensitization on Clinical and Functional Aspects of Psoriatic Arthritis” by Mehmet Nur Kaya et al. examines the prevalence of central sensitization (CS) in patients with psoriatic arthritis (PsA). Conducted with 103 PsA patients, the research used the Central Sensitization Inventory (CSI) to assess CS’s influence on clinical and functional markers such as disease activity, sleep quality, depression, and anxiety. The study found that 65.1% of the patients had CS, with the Psoriasis Area Severity Index (PASI), General Anxiety Disorder-7 (GAD-7), and Insomnia Severity Index (ISI) emerging as significant predictors of CS. Patients with CS demonstrated higher BMI and disease activity scores. The research highlights the importance of considering CS when assessing pain sensitivity in PsA patients. These findings underscore the potential impact of CS on clinical management, with implications for treatment strategies aimed at improving quality of life in PsA patients.

Profile:

Education

Mehmet Nur Kaya, a distinguished researcher in the field of rheumatology, earned his medical degree from a reputable institution and pursued further specialization in rheumatology. He is currently affiliated with the Rheumatology Department at Gülhane Training and Research Hospital, University of Health Sciences in Turkey. His academic journey reflects a commitment to understanding complex rheumatic diseases, particularly psoriatic arthritis (PsA). Through continuous learning and hands-on experience, Kaya has honed his skills in clinical research, diagnostics, and patient care, contributing to the advancement of medical knowledge in his field. His educational background, coupled with extensive clinical experience, has enabled him to conduct pioneering studies on central sensitization in PsA, shedding light on critical aspects of pain management and disease activity. Kaya’s dedication to education and research underscores his role as a key contributor to both academic and clinical advancements in rheumatology.

 

Professional Experiences

Dr. Mehmet Nur Kaya is a dedicated rheumatologist with extensive experience in the study and management of psoriatic arthritis (PsA) and other rheumatic conditions. As part of the Rheumatology Department at Gülhane Training and Research Hospital, University of Health Sciences, Turkey, he has made significant contributions to understanding the clinical and functional impacts of central sensitization (CS) on PsA patients. Dr. Kaya has collaborated with renowned professionals, leading numerous observational studies focused on pain sensitivity, quality of life, disease activity, and treatment outcomes in rheumatic diseases. His work with patient-centric assessments, such as the Central Sensitization Inventory (CSI), has played a critical role in shaping treatment protocols and improving patient care. Dr. Kaya is committed to advancing the field of rheumatology, combining clinical expertise with a passion for research, and continually striving to enhance the quality of life for individuals affected by chronic inflammatory diseases.

 

Research Skills

Research skills are essential for effectively gathering, analyzing, and interpreting information across various fields. These skills encompass critical thinking, allowing individuals to evaluate sources, discern credible information, and synthesize diverse viewpoints. Proficiency in quantitative and qualitative research methodologies is crucial, enabling researchers to design studies, collect data, and draw valid conclusions. Effective communication is another vital component, as researchers must articulate their findings clearly through written reports and presentations. Additionally, strong organizational skills facilitate the management of research timelines, resources, and documentation. Familiarity with digital tools and databases enhances the ability to access and utilize a wide range of resources efficiently. Lastly, ethical considerations in research, such as maintaining integrity and respecting confidentiality, are paramount to uphold the credibility of one’s work. Developing these research skills not only fosters academic and professional growth but also contributes to informed decision-making in an increasingly complex world.

Award And Recognition

The Research for Young Scientist Award recognizes outstanding contributions made by emerging researchers in the field of medical sciences, specifically focusing on the impact of central sensitization on psoriatic arthritis. This award aims to honor innovative research that enhances our understanding of chronic inflammatory diseases and their effects on patients’ quality of life. Candidates are evaluated based on their scientific rigor, originality, and potential for future contributions to the field. The award serves not only to celebrate individual achievements but also to inspire young scientists to pursue impactful research that addresses pressing health challenges. By fostering a culture of excellence and innovation, the Research for Young Scientist Award promotes the dissemination of knowledge and encourages collaboration among researchers. This recognition plays a crucial role in motivating young professionals to advance their careers and contribute significantly to the medical community.

Conclusion

The research conducted by Kaya et al. on the impact of central sensitization (CS) in patients with psoriatic arthritis (PsA) provides crucial insights into the complex interplay between pain sensitivity and disease severity. Their findings reveal that a significant proportion of PsA patients experience CS, which is associated with higher disease activity, impaired quality of life, and increased severity of psychological symptoms such as anxiety and insomnia. By utilizing the Central Sensitization Inventory (CSI), the study effectively highlights the importance of recognizing CS as a critical factor influencing the clinical and functional outcomes of PsA. The results underscore the need for healthcare professionals to consider CS in pain management strategies, aiming to improve the overall treatment approach for PsA patients. This research not only enhances the understanding of pain mechanisms in PsA but also emphasizes the necessity of comprehensive assessments to tailor interventions that address both physical and psychological aspects of the disease.

Publication Top Notes

  1. Drug-free remission is an achievable target with immunosuppressive treatment in idiopathic granulomatous mastitis
    Authors: Kaya, M.N., Tekgöz, E., Çolak, S., Çınar, M., Yılmaz, S.
    Year: 2023
    Citations: 3
    Journal: Irish Journal of Medical Science, 192(6), pp. 2815–2819
  2. Can pre-treatment inflammatory biomarker levels predict the response of tocilizumab therapy in COVID-19 patients?
    Authors: Kaya, M.N., Tecer, D., Çınar, M., Çolak, S., Yılmaz, S.
    Year: 2023
    Citations: 1
    Journal: Gulhane Medical Journal, 65(4), pp. 145–151
  3. Hospital-acquired anemia in chronic kidney disease
    Authors: Kaya, M.N., Caner, B., Toprak, Ö.
    Year: 2019
    Citations: 0
    Journal: International Journal of Scientific and Technology Research, 8(4), pp. 160–166

Rainer Pooth | Medicine and Dentistry Award | Best Innovation Award

Published on by Global Academic Awards

Dr. Rainer Pooth | Medicine and Dentistry Award | Best Innovation Award

Dr. Rainer Pooth, ICAAN GmbH, Germany

Based on the information provided, Dr. Rainer Pooth appears to be a highly suitable candidate for the “Research for Best Innovation Award” in the pharmaceutical and medical industry. Here’s an assessment of his qualifications:

Publication profile

Professional Experience & Leadership

Dr. Pooth has over 20 years of experience in the global pharmaceutical and medical industry, with a strong track record of leadership in multidisciplinary teams at both global and affiliate levels. His roles as Managing Director, Global Head of Medical/Scientific Affairs, and Head of Global Clinical Development demonstrate his ability to lead and innovate in complex, highly regulated environments. His strategic input in global R&D programs, project management, and regulatory affairs underscores his expertise in driving innovation and ensuring successful product development.

Achievements & Expertise

Dr. Pooth’s achievements include multiple approvals of medicinal products and medical devices across key global markets such as the EU, US, Australia, and Asia. He holds more than 35 patents, with a significant portion becoming commercially relevant, highlighting his innovative contributions to the field. His extensive publication record, including over 50 publications in international journals and books, as well as his role as an invited speaker at major scientific congresses, further cements his reputation as a leader in pharmaceutical research and innovation.

Global Impact & Collaboration

Dr. Pooth’s global network of experts and key opinion leaders, along with his experience in managing international submission teams and regulatory interactions, illustrates his ability to navigate and influence the global pharmaceutical landscape. His leadership in directing high-level global teams and managing collaborations with regulatory authorities and contract research organizations (CROs) demonstrates his capability to bring innovative products to market successfully.

Publication Top Notes

  • “Treatment of Refractory Cardiac Arrest by Controlled Reperfusion of the Whole Body” – A study exploring CARL in a multicenter setting, highlighting its impact on refractory cardiac arrest patients (2023).
  • “The Impact of Head Position on Neurological and Histopathological Outcome Following CARL” – Investigates how head positioning affects outcomes in a pig model during CARL (2023).
  • “Extracorporeal Cardiopulmonary Resuscitation—Evidence and Implications” – Discusses ECPR’s evidence base and its clinical implications (2023).
  • “Effects of Prolonged Serum Calcium Suppression during ECPR in Pigs” – Examines the effects of serum calcium suppression during ECPR, showing implications for treatment strategies (2023).
  • “Limiting Calcium Overload after Cardiac Arrest” – Focuses on the role of albumin in reducing calcium overload during CARL (2023).
  • “Pervasive Platelet Secretion Defects in SARS-CoV-2 Patients” – Analyzes platelet defects in COVID-19 patients and their potential implications for treatment (2023).
  • “CARL – Controlled Reperfusion of the Whole Body” – A book detailing the CARL procedure, providing a comprehensive resource for clinicians (2022).
  • “Observational Study on Implications of the COVID-19-Pandemic for Cardiopulmonary Resuscitation” – Examines the pandemic’s impact on resuscitation practices, offering valuable insights (2022).
  • “Monitoring Mitochondrial Partial Oxygen Pressure During Cardiac Arrest and ECPR” – A pilot study exploring mitochondrial oxygen monitoring during cardiac arrest in a pig model (2021).
  • “Brain Vulnerability and Viability after Ischaemia” – A review on the neurological outcomes following ischemic events, highlighting vulnerabilities and potential treatment avenues (2021).

Conclusion

Dr. Pooth’s extensive experience, significant contributions to the development and approval of innovative pharmaceutical products, and his leadership in global research and development make him a strong candidate for the “Research for Best Innovation Award.” His work has had a substantial impact on multiple therapeutic areas, including dermatology, immunology, aesthetic medicine, oncology, and neurology, making him well-deserving of recognition in this prestigious category.